Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis.
Jeffrey R CurtisIain B McInnesProton RahmanDafna D GladmanSteven PetersonFeifei YangOluwakayode AdejoroAlexa P KollmeierNatalie J ShiffChenglong HanMay ShawiWilliam TillettPhillip J MeasePublished in: Rheumatology and therapy (2024)
Clinicaltrials.gov identifier: NCT03158285.